The Board of Directors is comprised of 4 members having a Cardiovascular Surgeon, Multinational Banker , Veteran Pharma Sales Professional and a Lady with Public Relations credentials. Idea is to have our Board of directors from all walks of life across nations to help consolidate our company as a truly global one. Upon getting listed in Stock Exchange, the Members of our Board are to be pragmatically appointed by the shareholders in line with companies norms as applicable.
The Board of Directors defines the strategic business objectives, propositions, guidelines and directions of the Company, and supervises their implementation in line with its policy framework and agreed time lines. Subject to the powers expressly attributed to the Shareholders General Body Meeting and within the scope of the company’s corporate purpose, the Board of Directors power cover all issues relating to the proper management of the company and through its decisions the Board determines all matters falling within its authority.
Each year, the Board of Directors shall conduct a review to ensure that there is an appropriate balance in its composition. In particular, the Board shall seek to ensure gender balance and a broad diversity of backgrounds and countries of origin, international experience, reflecting Mubin Lab's status as a diversified global business conglomerate.
Mubin Lab's will be a professionally managed company whose "Executive Committee (EC)" shall be chaired by the Chief Executive Officer (CEO). This EC will have Permanent Members such as COO, CSO, CFO, CHR and CRO whose business shall be conducted by Public Relations Department who shall share and publish Minutes of Meeting (MoM) among others. It will have Guest Members who shall be called upon based on exigencies from time to time. EC will meet at least once in a month with or without Media Presence as and when warranted.